Oppenheimer Issues Positive Forecast for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH) had its target price hoisted by analysts at Oppenheimer from $420.00 to $500.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. Oppenheimer’s price target indicates a potential upside of 15.94% from the company’s current price.

Several other brokerages have also recently issued reports on UNH. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a research note on Wednesday, May 27th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $453.00 to $468.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 30th. Leerink Partners upped their target price on UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a report on Wednesday, June 17th. Mizuho upped their price target on shares of UnitedHealth Group from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Jefferies Financial Group raised their price target on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research note on Monday, April 20th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $444.75.

UnitedHealth Group Trading Up 1.9%

UNH traded up $7.88 on Friday, reaching $431.26. 2,861,844 shares of the company’s stock were exchanged, compared to its average volume of 8,441,774. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $461.62. The company’s 50 day moving average is $403.87 and its 200-day moving average is $341.69. The company has a market cap of $391.64 billion, a price-to-earnings ratio of 32.55, a PEG ratio of 1.68 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.87 by $1.51. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the previous year, the business posted $4.08 EPS. The firm’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts predict that UnitedHealth Group will post 18.39 earnings per share for the current year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.28% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Ares Financial Consulting LLC lifted its position in shares of UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock valued at $174,000 after acquiring an additional 28 shares in the last quarter. Founders Capital Management LLC boosted its position in UnitedHealth Group by 3.0% during the 4th quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate’s stock worth $324,000 after acquiring an additional 29 shares during the period. Kellett Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 1.7% during the fourth quarter. Kellett Wealth Advisors LLC now owns 1,746 shares of the healthcare conglomerate’s stock worth $576,000 after purchasing an additional 29 shares during the period. Rockland Trust Co. grew its holdings in shares of UnitedHealth Group by 1.1% during the 2nd quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock valued at $1,076,000 after acquiring an additional 29 shares in the last quarter. Finally, Matrix Trust Co increased its position in UnitedHealth Group by 24.8% in the 2nd quarter. Matrix Trust Co now owns 146 shares of the healthcare conglomerate’s stock worth $61,000 after purchasing an additional 29 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth delivered a large Q2 earnings beat, with adjusted EPS of $6.38 topping estimates and revenue also coming in above forecasts, signaling stronger-than-expected operating performance. UnitedHealth Group Reports Second Quarter 2026 Results
• Positive Sentiment: The company raised full-year 2026 guidance to $19.50-$20.00 in adjusted EPS and increased operating cash flow and buyback targets, which supports confidence in the turnaround story and capital returns. UnitedHealth raises 2026 forecast as it controls medical costs
• Positive Sentiment: Multiple analysts lifted price targets and earnings forecasts after the beat, reinforcing the view that the stock still has upside if execution continues to improve. UnitedHealth Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results
• Neutral Sentiment: Management said Medicare and Optum are improving, but commercial cost pressures are still delaying a full margin recovery, so the earnings reset is not fully complete yet. UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
• Neutral Sentiment: Several reports highlighted that the rally was driven mainly by earnings and guidance, with broader health-care sector strength and upbeat analyst commentary adding support rather than a new standalone catalyst. Use These ETFs as Health Stocks LLY, UNH, MRK Thrive

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.